Scientists from the Institute of Cancer Research (ICR), London, UK, have developed an algorithm that can predict whether individuals with inflammatory bowel disease (IBD) will develop bowel cancer within five years with an accuracy of more than 90%.

A new method for detecting bowel cancer is more than 90% accurate at predicting which higher-risk people will develop the disease, according to research. About 500,000 people in the UK live with inflammatory bowel disease (IBD), including Crohn's and ulcerative colitis.

A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop the disease, research has shown. People with inflammatory bowel

This method will brings us closer to a potential blood test that could help doctors identify which IBD patients are most at risk

The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.

A new DNA test developed in the UK can accurately predict whether high-risk patients will develop colorectal cancer in the five years. People with inflammatory bowel disease (IBD) — which includes conditions like ulcerative colitis and Crohn’s — are up to four times more likely to get this type of cancer,

Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.